Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Artrya Limited ( (AU:AYA) ) has shared an update.
Artrya Limited reported a loss of $7.44 million for the half-year ending December 31, 2024, marking an 8.2% increase in losses compared to the previous year. The company did not declare any dividends during this period, and its net tangible assets per ordinary security decreased from 14.07 cents to 11.08 cents, reflecting ongoing financial challenges.
More about Artrya Limited
Artrya Limited operates in the healthcare industry, focusing on developing and providing advanced medical imaging solutions. The company specializes in innovative technologies aimed at improving the diagnosis and management of cardiovascular diseases.
YTD Price Performance: 58.49%
Average Trading Volume: 163,010
Technical Sentiment Consensus Rating: Sell
For a thorough assessment of AYA stock, go to TipRanks’ Stock Analysis page.